Figure 1From: Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion Diagram of 2-step indirect comparison methodology with evidence sources based on multinomial model for probabilities of change in BCVA from baseline for dexamethasone and Bayesian indirect comparison of dexamethasone with ranibizumab. Back to article page